Jane Street’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $904K | Buy |
+44,071
| New | +$904K | ﹤0.01% | 2990 |
|
|
2025
Q1 | – | Sell |
-29,257
| Closed | -$662K | – | 6024 |
|
|
2024
Q4 | $662K | Buy |
+29,257
| New | +$662K | ﹤0.01% | 3522 |
|
|
2024
Q3 | – | Sell |
-183,147
| Closed | -$4.23M | – | 6213 |
|
|
2024
Q2 | $4.23M | Buy |
183,147
+83,884
| +85% | +$1.94M | ﹤0.01% | 1861 |
|
|
2024
Q1 | $2.39M | Sell |
99,263
-386,996
| -80% | -$9.32M | ﹤0.01% | 2106 |
|
|
2023
Q4 | $11.2M | Buy |
486,259
+330,500
| +212% | +$7.6M | ﹤0.01% | 863 |
|
|
2023
Q3 | $3.17M | Buy |
155,759
+103,871
| +200% | +$2.11M | ﹤0.01% | 1751 |
|
|
2023
Q2 | $1.21M | Sell |
51,888
-3,315
| -6% | -$77.4K | ﹤0.01% | 2878 |
|
|
2023
Q1 | $1.28M | Sell |
55,203
-29,172
| -35% | -$679K | ﹤0.01% | 2537 |
|
|
2022
Q4 | $2.12M | Buy |
84,375
+56,843
| +206% | +$1.43M | ﹤0.01% | 1946 |
|
|
2022
Q3 | $727K | Sell |
27,532
-76,885
| -74% | -$2.03M | ﹤0.01% | 3160 |
|
|
2022
Q2 | $3.02M | Buy |
104,417
+47,247
| +83% | +$1.37M | ﹤0.01% | 1523 |
|
|
2022
Q1 | $1.97M | Sell |
57,170
-91,990
| -62% | -$3.17M | ﹤0.01% | 2160 |
|
|
2021
Q4 | $6.54M | Buy |
149,160
+124,210
| +498% | +$5.44M | ﹤0.01% | 898 |
|
|
2021
Q3 | $1.27M | Sell |
24,950
-16,164
| -39% | -$820K | ﹤0.01% | 2383 |
|
|
2021
Q2 | $2.14M | Sell |
41,114
-174,927
| -81% | -$9.1M | ﹤0.01% | 1701 |
|
|
2021
Q1 | $9.88M | Buy |
216,041
+182,225
| +539% | +$8.33M | ﹤0.01% | 491 |
|
|
2020
Q4 | $1.55M | Buy |
+33,816
| New | +$1.55M | ﹤0.01% | 1705 |
|
|
2020
Q3 | – | Sell |
-30,721
| Closed | -$1.17M | – | 4062 |
|
|
2020
Q2 | $1.17M | Buy |
+30,721
| New | +$1.17M | ﹤0.01% | 1815 |
|
|
2019
Q3 | – | Sell |
-32,391
| Closed | -$880K | – | 3684 |
|
|
2019
Q2 | $880K | Buy |
+32,391
| New | +$880K | ﹤0.01% | 1764 |
|